Hycodan and Pemetrexed drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Hycodan (homatropine methylbromide; hydrocodone bitartrate) and Pemetrexed (pemetrexed). Common drug interactions include pleural effusion among females and lymphangiosis carcinomatosa among males.

The phase IV clinical study analyzes what interactions people have when they take Hycodan and Pemetrexed. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.

What is Hycodan?

Hycodan has active ingredients of homatropine methylbromide; hydrocodone bitartrate. It is often used in cough. eHealthMe is studying from 769 Hycodan users. Check the latest studies of Hycodan.

What is Pemetrexed?

Pemetrexed has active ingredients of pemetrexed. eHealthMe is studying from 17,491 Pemetrexed users. Check the latest studies of Pemetrexed.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 02, 2026

14 people who take Hycodan and Pemetrexed together, and have interactions are studied.

Hycodan and Pemetrexed drug interactions.

What are the common drug interactions of Hycodan and Pemetrexed, by gender? *:

female:

  1. Pleural effusion (water on the lungs)
  2. Arthralgia (joint pain)
  3. Blood iron decreased
  4. Bone pain
  5. Dysphagia (a condition in which swallowing is difficult or painful)
  6. Embolism (obstruction of an artery, typically by a clot of blood or an air bubble)
  7. Febrile neutropenia (fever with reduced white blood cells)
  8. Fungal infection
  9. Infection
  10. Neoplasm progression (growth of tumour)

male:

  1. Lymphangiosis carcinomatosa (inflammation of the lymph vessels can lead to cancer)
  2. Respiratory failure (inadequate gas exchange by the respiratory system)
  3. Constipation
  4. Dehydration (dryness resulting from the removal of water)
  5. Duodenal ulcer
  6. Gastric ulcer (stomach ulcer)
  7. Haemoglobin decreased
  8. Hypoalbuminaemia (levels of albumin in blood serum are abnormally low)
  9. Intestinal ulcer
  10. Oedema peripheral (superficial swelling)

What are the common drug interactions of Hycodan and Pemetrexed, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Febrile neutropenia (fever with reduced white blood cells)

40-49:

  1. Arthralgia (joint pain)
  2. Blood iron decreased
  3. Bone pain
  4. Dysphagia (a condition in which swallowing is difficult or painful)
  5. Fungal infection
  6. Infection
  7. Neoplasm progression (growth of tumour)
  8. Non-small cell lung cancer metastatic (type of epithelial lung cancer spreads to other parts)
  9. Odynophagia (painful swallowing, in the mouth (oropharynx) or oesophagus)
  10. Oesophageal fistula (a birth defect, with the trachea connected to the oesophagus)

50-59:

  1. Pleural effusion (water on the lungs)
  2. Embolism (obstruction of an artery, typically by a clot of blood or an air bubble)
  3. Portal vein thrombosis (venous thrombosis affecting the hepatic portal vein)

60+:

  1. Lymphangiosis carcinomatosa (inflammation of the lymph vessels can lead to cancer)
  2. Respiratory failure (inadequate gas exchange by the respiratory system)
  3. Constipation
  4. Dehydration (dryness resulting from the removal of water)
  5. Duodenal ulcer
  6. Gastric ulcer (stomach ulcer)
  7. Haemoglobin decreased
  8. Hypoalbuminaemia (levels of albumin in blood serum are abnormally low)
  9. Intestinal ulcer
  10. Oedema peripheral (superficial swelling)

What are the existing conditions these people have? *

  1. Lung Cancer - Non-Small Cell (lung cancer): 10 people, 71.43%
  2. High Blood Pressure: 5 people, 35.71%
  3. Nausea (feeling of having an urge to vomit): 5 people, 35.71%
  4. Appetite - Increased (increased appetite is when you want to eat much more often or in larger quantities than your body requires): 3 people, 21.43%
  5. Constipation: 3 people, 21.43%
  6. Prostate Cancer: 3 people, 21.43%
  7. Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it): 3 people, 21.43%
  8. High Blood Cholesterol: 3 people, 21.43%
  9. Coronary Heart Disease (narrowing or blockage of the coronary arteries): 2 people, 14.29%
  10. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 14.29%

* Approximation only. Some reports may have incomplete information.

Do you take Hycodan and Pemetrexed?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Hycodan and Pemetrexed:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Hycodan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Pemetrexed:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Hycodan and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Pemetrexed and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on homatropine methylbromide; hydrocodone bitartrate and pemetrexed (the active ingredients of Hycodan and Pemetrexed, respectively), and Hycodan and Pemetrexed (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: